Nasal cartilage relieves osteoarthritis in the knee
University of Basel
Human articular cartilage defects can be treated with cells taken from the
nasal septum. Image source: University of Basel, Christian Flierl
A research team at the Department of Biomedicine of the University of Basel and the University Hospital of Basel is cultivating cartilage tissue from cells of the nasal septum to repair articular cartilage in the knee.
The team led by Professor
Ivan Martin and Professor Andrea Barbero has already succeeded in doing this in
initial clinical studies on isolated cartilage damage, and they have now
reported that the approach could also be suitable for degenerative joint
diseases such as osteoarthritis. Their findings have been published in the
journal Science
Translational Medicine.
Osteoarthritis
is associated with cartilage degradation, which can cause severe pain and
reduce mobility. The therapeutic approach up to now aims at palliative
treatment of the inflammation and pain until a knee joint replacement by a
prosthetic implant becomes unavoidable. Joint prostheses, however, have a
limited durability, which makes the treatment problematic, especially in
younger patients.
From the nose to the knee
A possible
alternative could be to repair the articular cartilage using engineered cartilage
tissue. To this end, the research team, in collaboration with orthopedic and
plastic surgeons from the University Hospital of Basel, takes a tissue sample
from a patient's nasal septum, cultivates the isolated cartilage cells and uses
them to grow a cartilage layer that is then surgically implanted into the knee
joint.
Unlike traumatic
and confined cartilage defects, for example following sports injuries, the
tissue environment in the osteoarthritic knee is characterized by persistent
inflammatory reactions. "First we had to test whether the cartilage
replacement was attacked and degenerated by the inflammatory factors,"
explains Ivan Martin.
The researchers led by Professor Martin's doctoral student Lina Acevedo Rua, project leader Dr. Karoliina Pelttari and orthopedic surgeon Dr. Marcus Mumme initially tested the cultured human cartilage tissue in the presence of inflammatory factors in various models in the laboratory and in small experimental animals.
They then
tested the durability of the cartilage tissue under simultaneous inflammatory
and mechanical stress, using cartilage cells from the nose of sheep in the
osteoarthritic knee joint of the same animals.
Cartilage cells with anti-inflammatory properties
The results of the animal experiments were encouraging -- not only did the tissue engineered from nasal cartilage cells prove to be extremely robust, it also seemed to counteract the inflammatory reactions.
Further analysis revealed that this
effect could be due to the fact that a molecular signaling pathway that is
chronically upregulated in osteoarthritis (the WNT signaling pathway) was
repressed by the presence of the nasal cartilage cells.
Explaining the
amazing properties of the nasal cartilage, Professor Martin says: "Unlike
the cartilage tissue in the joints, these cartilage cells originate from
precursor cells of the neuroectoderm and therefore have a distinct regenerative
and adaptive capacity (plasticity). Tissue grown from nasal cartilage cells
seems also to retain these special properties."
Following the
successful trials on animals, the researchers also tested the approach on two
young patients suffering from severe osteoarthritis, likely due to misalignment
of the leg bones. Their alternative treatment would have been a knee joint
prosthesis.
Less pain, recovered joint
Following the implantation of the cartilage engineered from the patients' own nasal cartilage cells, the two subjects reported a reduction in pain and increased quality of life. In one of the two patients, the researchers were also able to determine via MRI images that the bones in the knee joint were further apart than previously -- an indication of the joint's recovery.
With the second patient,
they were unable to perform any MRI scans due to travel restrictions during the
pandemic, and could only interview him to derive a subjective assessment.
In addition, as
the misalignment of the bones in both patients could be surgically corrected
and thus the most likely cause of their osteoarthritis eliminated, the
researchers are confident that patients will be able to manage without knee
joint prostheses, at least for some time.
"Our results have enabled us to lay the biological foundation for a therapy, and we are cautiously optimistic" says Martin.
This approach will first have to
be further assessed for the treatment of patellofemoral osteoarthritis through
in-depth clinical trials, for which the team is receiving financial support as
part of an Innovation Focus ("Regenerative Surgery") by the
University Hospital of Basel. The researchers also aim to further develop the
method for other types of osteoarthritis in order to be able to treat a broader
spectrum of patients.
